These findings were confirmed by the immunohistochemistry analysis that showed that IL-17B, p-MLKL, and p-RIP3 were increased with DVT and IL-17B treatment but decreased with anti-IL-17B (Figures 4(d) and 4(e)). This evidence concerns the gene MLKL and deep vein thrombosis.